The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe.
Open accessAbstract
Background & aims Moderate cure rates of acute hepatitis C virus (HCV) infections with pegylated interferon and ribavirin have been described in the last decade in men who have sex with men (MSM), who are also coinfected with the human immunodeficiency virus (HIV). However, a subsequent high incidence of HCV reinfections has been reported regionally in men who both clear the infection spontaneously or who respond to treatment.Methods Retrospective analysis of reinfections in HIV infected MSM in eight centers from Austria, France, Germany, and the UK within the NEAT network between May 2002 and June 2014.Results Of 606 individuals who cleared HCV spontaneously or were successfully treated, 149 (24.6%) presented with a subsequent HCV reinfection. Thirty out of 70 (43%) who cleared again or were successfully treated, presented with a second reinfection, 5 with a third, and one with a fourth reinfection. The reinfection incidence was 7.3/100 person-years (95% CI 6.2-8.6). We found a trend for lower incidence among individuals who had spontaneously cleared their incident infection than among individuals who were treated (Hazard ratio 0.62, 95% CI 0.38-1.02, p=0.06). Spontaneous clearance of reinfection was associated with ALT levels >1000IU/ml and spontaneous clearance of a prior infection.Conclusions HCV reinfection is an issue of major concern in HIV-positive MSM. Prevention strategies are needed for high risk groups to reduce morbidity and treatment costs. HIV-positive MSM with a prior HCV infection should be tested every 3 to 6months for reinfection. Those who had achieved a reinfection should be tested every 3months.Lay summary We evaluated the occurrence of HCV reinfection in HIV-positive men who have sex with men. We found an alarming incidence of 7.3/100 person-years. Prevention measures need to address this specific subgroup of patients at high risk for HCV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Because acute HCV infection acquisition among persons with HIV infection can occur, especially among MSM, and regular screening of those with HIV is cost-effective (238,239,1377), periodic HCV screening should be conducted (1378–1380).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [1380]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smith, C. J., Ryom, L., Weber, R. K., Morlat, P., Pradier, C., Reiss, P., Kowalska, J. D., Wit, S. D., Law, M. G., El‐Sadr, W., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60604-8 · Cited by 950
The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies
Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J. C., Strazzera, A., Chien, D. Y., Muñoz, S. J., Balestrieri, A., et al. (2000) · Science · doi:10.1126/science.288.5464.339 · Cited by 882
Pestka, J. M., Zeisel, M. B., Bläser, E., Schürmann, P., Bartosch, B., Cosset, F., Patel, A. H., Meisel, H., Baumert, J. J., Viazov, S. O., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607026104 · Cited by 565
Martin, N. K., Vickerman, P. T., Grebely, J., Hellard, M. E., Hutchinson, S. J., Lima, V. D., Foster, G. R., Dillon, J. F., Goldberg, D. J., Dore, G. J., et al. (2013) · Hepatology · doi:10.1002/hep.26431 · Cited by 488
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Naggie, S., Cooper, C., Saag, M. S., Workowski, K., Ruane, P. J., Towner, W. J., Marks, K., Luetkemeyer, A. F., Baden, R. P., Sax, P. E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501315 · Cited by 467
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1
Wyles, D. L., Ruane, P. J., Sulkowski, M., Dieterich, D. T., Luetkemeyer, A. F., Morgan, T. R. M., Sherman, K. E., Dretler, R. H., Fishbein, D. A., Gathe, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503153 · Cited by 411
Danta, M., Brown, D., Bhagani, S., Pybus, O. G., Sabin, C. A., Nelson, M., Fisher, M., Johnson, A. M., & Dusheiko, G. M. (2007) · AIDS · doi:10.1097/qad.0b013e3281053a0c · Cited by 410
Self-citationOsburn, W. O., Fisher, B. E., Dowd, K. A., Urban, G., Liu, L., Ray, S. C., Thomas, D. L., & Cox, A. L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.017 · Cited by 360
Bourne, A. H., Reid, D., Hickson, F. C. I., Rueda, S. T., & Weatherburn, P. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052052 · Cited by 330
Tillmann, H. L., Thompson, A. J. V., Patel, K., Wiese, M., Tenckhoff, H., Nischalke, H. D., Lokhnygina, Y. V., Kullig, U., Göbel, U., Capka, E., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.005 · Cited by 321
Cited by
Sorted by citations
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Bhattacharya, D., Aronsohn, A. I., Price, J. C., Re, V. L., Heald, J., Demisashi, G., Durzy, E., Davis-Owino, A., & Tynes, S. A. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad319 · Cited by 345
The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations
Safreed‐Harmon, K., Thursz, M. R., Dillon, J. F., El-Sayed, M. H., Elsharkawy, A. M., Hatzakis, A. E., Jadoul, M. Y., Prestileo, T., Razavi, H. A., Rockstroh, J. K., et al. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1666841 · Cited by 262
Self-citationBreakthroughs in hepatitis C research: from discovery to cure
Manns, M. P., & Maasoumy, B. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00608-8 · Cited by 242
Martinello, M., Solomon, S. S., Terrault, N. A., & Dore, G. J. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01320-x · Cited by 204
Boerekamps, A., van den Berk, G. E. L., Lauw, F. N., Leyten, E. M. S., van Kasteren, M. E. E., van Eeden, A., Posthouwer, D., Claassen, M. A. A., Dofferhoff, A. S. M., Verhagen, D. W. M., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1007 · Cited by 169
Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection
Vermehren, J., Park, J. S., Jacobson, I. M., & Zeuzem, S. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.07.002 · Cited by 118
Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study
Islam, N., Krajden, M., Shoveller, J., Gustafson, P., Gilbert, M., Buxton, J. A., Wong, J., TYNDALL, M. W., & Janjua, N. Z. (2016) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30182-0 · Cited by 109
Nijmeijer, B. M., Koopsen, J., Schinkel, J., Prins, M., & Geijtenbeek, T. B. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25348 · Cited by 100
Understanding and addressing hepatitis C reinfection in the oral direct‐acting antiviral era
Falade-Nwulia, O. O., Sulkowski, M., Merkow, A., Latkin, C. A., & Mehta, S. H. (2018) · Journal of Viral Hepatitis · doi:10.1111/jvh.12859 · Cited by 100
Management of acute HCV infection in the era of direct-acting antiviral therapy
Martinello, M., Hajarizadeh, B., Grebely, J., Dore, G. J., & Matthews, G. V. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0026-5 · Cited by 97
Rockstroh, J. K., Bhagani, S. R., Hyland, R. H., Yun, C., Dvory‐Sobol, H., Zheng, W., Brainard, D. M., Ingiliz, P., Lutz, T., Boesecke, C., et al. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(17)30003-1 · Cited by 79
Self-citationHigh incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis
Hoornenborg, E., Coyer, L., Boyd, A. C., Achterbergh, R., van der Loeff, M. F. S., Bruisten, S. M., de Vries, H. J. C., Koopsen, J., van de Laar, T. J. W., Prins, M., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.11.022 · Cited by 72
Aregay, A., Sekyere, S. O., Deterding, K., Port, K., Dietz, J., Berkowski, C., Sarrazin, C., Manns, M. P., Cornberg, M., & Wedemeyer, H. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.025 · Cited by 70
Smit, C., Boyd, A. C., Rijnders, B. J. A., van de Laar, T. J. W., Leyten, E. M. S., Bierman, W. F. W., Brinkman, K., Claassen, M. A. A., den Hollander, J., Boerekamps, A., et al. (2020) · The Lancet HIV · doi:10.1016/s2352-3018(20)30301-5 · Cited by 68
Ingiliz, P., Wehmeyer, M. H., Boesecke, C., Wiesch, J. S. Z., Schewe, K., Lutz, T. A., Baumgarten, A., Simon, K., Hueppe, D., Rockstroh, J. K., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz949 · Cited by 68
Self-citationNewsum, A. M., Matser, A. A., Schinkel, J., van der Valk, M., Brinkman, K., van Eeden, A., Lauw, F. N., Rijnders, B. J. A., van de Laar, T. J. W., van de Kerkhof, M., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa645 · Cited by 70
Boerekamps, A., Newsum, A. M., Smit, C., Arends, J. E., Richter, C., Reiss, P., Rijnders, B. J. A., Brinkman, K., van der Valk, M., NVHB-SHM Hepatitis Working Group and the Netherlands ATHENA HIV Observational Cohort, et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1004 · Cited by 67
Millman, A. J., Nelson, N. P., & Vellozzi, C. J. (2017) · Current Epidemiology Reports · doi:10.1007/s40471-017-0108-x · Cited by 70
Hepatitis C virus spread from HIV-positive to HIV-negative men who have sex with men
Charre, C., Cotte, L., Kramer, R., Miailhes, P., Godinot, M., Koffi, J., Scholtès, C., & Ramière, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190340 · Cited by 65
Martinello, M., Yee, J., Bartlett, S. R., Read, P. J., Baker, D. A., Post, J. J., Finlayson, R. J., Bloch, M., Doyle, J., Shaw, D., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz985 · Cited by 65
Epidemiology and Elimination of HCV-Related Liver Disease
Pradat, P., Virlogeux, V., & Trépo, E. (2018) · Viruses · doi:10.3390/v10100545 · Cited by 64
Hosseini‐Hooshyar, S., Hajarizadeh, B., Bajis, S., Law, M. G., Janjua, N. Z., Fierer, D. S., Chromy, D., Rockstroh, J. K., Martin, T., Ingiliz, P., et al. (2021) · SSRN Electronic Journal · doi:10.1016/s2352-3018(22)00077-7 · Cited by 59
Self-citationHCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs
Martinello, M., Hajarizadeh, B., Grebely, J., Dore, G. J., & Matthews, G. V. (2017) · Current HIV/AIDS Reports · doi:10.1007/s11904-017-0358-8 · Cited by 55
Berenguer, J., Gil‐Martin, Á., Jarrín, I., Montes, M., Domínguez, L., Aldámiz‐Echevarría, T., Téllez, M. J., Santos, I. D. L., Troya, J., Losa, J. E., et al. (2018) · AIDS · doi:10.1097/qad.0000000000002103 · Cited by 53
for the ANRS-Prevagay group, Vaux, S., Chevaliez, S., Saboni, L., Sauvage, C., Sommen, C., Barin, F., Alexandre, A. F., Jauffret‐Roustide, M., Lot, F., et al. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3945-z · Cited by 53
Ackermann, C., Smits, M., Woost, R., Eberhard, J. M., Peine, S., Kummer, S., Marget, M., Kuntzen, T., Kwok, W. W., Lohse, A. W., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47024-8 · Cited by 50
Hepatitis C: Standard of Treatment and What to Do for Global Elimination
Marco, L. D., Mantia, C. L., & Marco, V. D. (2022) · Viruses · doi:10.3390/v14030505 · Cited by 46
Willig, A. L., Wright, L. Y., & Galvin, T. A. (2018) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2017.12.007 · Cited by 42
Martin, N. K., Boerekamps, A., Hill, A. M., & Rijnders, B. J. A. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25062 · Cited by 43
Boerekamps, A., Weggheleire, A. D., van den Berk, G. E. L., Lauw, F. N., Claassen, M. A. A., Posthouwer, D., Bierman, W. F. W., Hullegie, S. J., Popping, S., van de Vijver, D. A. M. C., et al. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(18)30414-x · Cited by 41
Lockart, I., Matthews, G. V., & Danta, M. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000515 · Cited by 37
Popping, S., Hullegie, S. J., Boerekamps, A., Rijnders, B. J. A., de Knegt, R. J., Rockstroh, J. K., Verbon, A., Boucher, C. A., Nichols, B. E., & van de Vijver, D. A. M. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210179 · Cited by 37
Self-citationHepatitis and Global Infectious Diseases Consensus Panel European Treatment Network for HIV (2020) · AIDS · doi:10.1097/qad.0000000000002622 · Cited by 35
Newsum, A. M., Stolte, I. G., van der Meer, J. T. M., Schinkel, J., van der Valk, M., Vanhommerig, J. W., Buvé, A., Danta, M., Hogewoning, A. A., Prins, M., et al. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.21.30540 · Cited by 34
Huang, M., Chang, S., Liu, C., Cheng, A., Su, L., Liu, W., Su, Y., Sun, H., Hung, C., & Chang, S. (2019) · Liver International · doi:10.1111/liv.14199 · Cited by 33
the Dat’AIDS Study Group, Virlogeux, V., Zoulim, F., Puglièse, P., Poizot‐Martin, I., Valantin, M., Cuzin, L., Reynes, J., Billaud, E., Huleux, T., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0979-1 · Cited by 35
Gonzalez, S. A., Fierer, D. S., & Talal, A. H. (2017) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0000000000000104 · Cited by 32
Reversal of T Cell Exhaustion in Chronic HCV Infection
Osuch, S., Metzner, K. J., & Cortés, K. C. (2020) · Viruses · doi:10.3390/v12080799 · Cited by 34
Popping, S., El-Sayed, M. H., Feld, J. J., Hatzakis, A. E., Hellard, M. E., Lesi, O. A., Ninburg, M. H., Ward, J., & Boucher, C. A. (2018) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30264-8 · Cited by 31
Martin, N. K., Jansen, K., der Heiden, M. A., Boesecke, C., Boyd, A. C., Schewe, K., Baumgarten, A., Lutz, T., Christensen, S., Thielen, A., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz367 · Cited by 30
Self-citationTransmission of hepatitis C virus in HIV‐positive and PrEP‐using MSM in England
Bradshaw, D., Vasylyeva, T. I., Davis, C., Pybus, O. G., Thézé, J., Thomson, E. C., Martinello, M., Matthews, G. V., Burholt, R., Gilleece, Y. C., et al. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13286 · Cited by 28
Self-citationHCV Microelimination for High-risk Special Populations
Huang, C., Chen, G., Hung, C., & Yu, M. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac446 · Cited by 27
Bradshaw, D., Mbisa, J. L., Geretti, A. M., Healy, B., Cooke, G., Foster, G. R., Thomson, E. C., McLauchlan, J., Agarwal, K., Sabin, C. A., et al. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.10.007 · Cited by 26
Chaillon, A., Sun, X., Cachay, E. R., Looney, D. J., Wyles, D. L., Garfein, R. S., Martin, T., Jain, S., Mehta, S. R., Smith, D. M., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz160 · Cited by 26
Self-citationEliminating viral hepatitis C in Belgium: the micro-elimination approach
Busschots, D., Toghanian, S., Bielen, R., Salomonsson, S., Koc, Ö. M., Hendrickx, G., Jadoul, M. Y., Nevens, F., Sokal, E. M., Brixko, C., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4898-y · Cited by 24
Karageorgopoulos, D. E. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i15.1936 · Cited by 23
Vizcaya, L. S., Wandeler, G., Fehr, J. S., Braun, D. L., Cavassini, M. L., Stoeckle, M. P., Bernasconi, E., Hoffmann, M., Rougemont, M., Béguelin, C., et al. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy154 · Cited by 22
Epidemic history of hepatitis C virus genotypes and subtypes in Portugal
Palladino, C., Ezeonwumelu, I. J., Marcelino, R., Briz, V., Moranguinho, I., Serejo, F., Velosa, J., Marinho, R. T., Borrego, P., & Taveira, N. (2018) · Scientific Reports · doi:10.1038/s41598-018-30528-0 · Cited by 22
Adu, P., Rossi, C., Binka, M., Wong, S., Wilton, J., Wong, J., Butt, Z. A., Bartlett, S., Jeong, D., Pearce, M., et al. (2020) · Liver International · doi:10.1111/liv.14762 · Cited by 21
Sun, H., Chiang, C., Huang, S., Guo, W.-J., Chuang, Y., Huang, Y., Yang, C., Su, L., Chen, Y.-T., Chen, Y.-W., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02437-21 · Cited by 21
Maasoumy, B., Ingiliz, P., Spinner, C. D., Cordes, C., Stellbrink, H., Wiesch, J. S. Z., Schneeweiß, S. M., Deterding, K., Müller, T., Kahlhöfer, J., et al. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100650 · Cited by 21
Self-citationHosseini‐Hooshyar, S., Martinello, M., Yee, J., Read, P. J., Baker, D. A., Post, J. J., Finlayson, R. J., Bloch, M., Doyle, J., Shaw, D., et al. (2020) · AIDS · doi:10.1097/qad.0000000000002562 · Cited by 22
The epidemiology of Hepatitis B, C and D in Germany: A scoping review
Steffen, G., Sperle, I., Leendertz, S. A. J., Sarma, N., Beermann, S., Thamm, M., Bremer, V., Zimmermann, R., & Dudareva, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229166 · Cited by 20
Pradat, P., Puglièse, P., Poizot‐Martin, I., Valantin, M., Cuzin, L., Reynes, J., Billaud, E., Huleux, T., Bani‐Sadr, F., Rey, D., et al. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.05.008 · Cited by 19
Shabil, M., Yadav, A., Shamim, M. A., Ahmed, M., Satapathy, P., Zaidan, A. A., Khatib, M. N., Gaidhane, S., Zahiruddin, Q. S., Rabaan, A. A., et al. (2024) · Health Science Reports · doi:10.1002/hsr2.2206 · Cited by 19
Understanding and Addressing Hepatitis C Virus Reinfection Among Men Who Have Sex with Men
Martin, T., Rauch, A., Vizcaya, L. S., & Martin, N. K. (2018) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2018.02.004 · Cited by 19
Self-citationChromy, D., Schmidt, R. L. J., Mandorfer, M., Lang, G. F., Bauer, D. J. M., Schwabl, P., Popow‐Kraupp, T., Reiberger, T., & Mayer, F. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz948 · Cited by 19
Self-citationCaro‐Pérez, N., Martínez‐Rebollar, M., Gregori, J., Quer, J., González, P., Gambato, M., García‐González, N., Gónzález‐Candelas, F., Costa, J. M., Esteban, J. I., et al. (2017) · Journal of Clinical Virology · doi:10.1016/j.jcv.2017.05.008 · Cited by 18
Aebi‐Popp, K., Wandeler, G., Vizcaya, L. S., Metzner, K. J., Stöckle, M., Cavassini, M. L., Hoffmann, M., Lüthi, A. U., Suter, F., Bernasconi, E., et al. (2018) · HIV Medicine · doi:10.1111/hiv.12602 · Cited by 18
Building a Hepatitis C Clinical Program: Strategies to Optimize Outcomes
Zuckerman, A. D., Carver, A. B., & Chastain, C. A. (2018) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-018-0177-5 · Cited by 18
Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor
Pilewski, K. A., Wall, S. C., Richardson, S. I., Manamela, N. P., Clark, K. E., Hermanus, T., Binshtein, E., Venkat, R., Sautto, G. A., Kramer, K. J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112044 · Cited by 18
High-Resolution Evolutionary Analysis of Within-Host Hepatitis C Virus Infection
Raghwani, J., Wu, C., Ho, C. K. Y., de Jong, M. D., Molenkamp, R., Schinkel, J., Pybus, O. G., & Lythgoe, K. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy747 · Cited by 17
Hepatitis C microelimination among people living with HIV in Taiwan
Chen, G., Ho, S., Su, L., Chang, S., Hsieh, S., Sheng, W., Liu, W.-D., Huang, Y., Lin, K., Chen, Y., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2081620 · Cited by 17
Huang, M., Chen, G., Sun, H., Chen, Y., Su, L., Ho, S., Chang, S., Huang, S., Huang, Y., Liu, W.-D., et al. (2023) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2023.01.006 · Cited by 16
The HCV care continuum does not end with cure: A call to arms for the prevention of reinfection
Falade-Nwulia, O. O., & Sulkowski, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.027 · Cited by 17
Koopsen, J., Parker, E., Han, A. X., van de Laar, T. J. W., Russell, C. A., Hoornenborg, E., Prins, M., van der Valk, M., & Schinkel, J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1830 · Cited by 15
The ‘Viennese epidemic’ of acute HCV in the era of direct‐acting antivirals
Chromy, D., Bauer, D. J. M., Simbrunner, B., Jachs, M., Hartl, L., Schwabl, P., Schwarz, C., Rieger, A., Grabmeier‐Pfistershammer, K., Trauner, M. A., et al. (2022) · Journal of Viral Hepatitis · doi:10.1111/jvh.13665 · Cited by 15
Self-citationMathematical modeling of HIV-HCV co-infection model: Impact of parameters on reproduction number
Abiodun, O. E., Adebimpe, O., Ndako, J. A., Oludoun, O. Y., Aladeitan, B. B., & Adeniyi, M. O. (2022) · F1000Research · doi:10.12688/f1000research.124555.1 · Cited by 15
Bourlière, M., Pietri, O., Castellani, P., Oulès, V., & Adhoute, X. (2018) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284818812358 · Cited by 15
Hepatitis C Virus Reinfection Among Men Who Have Sex With Men With HIV in New York City
Fierer, D. S., Carollo, J. R., Rodriguez-Caprio, G., Radix, A., Vail, R. M., Chavez, R., Bungay, K., Dillon, S. M., for the New York Acute Hepatitis C Surveillance Network, Akil, B., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae297 · Cited by 14
Direct-acting antivirals and chronic hepatitis C: towards elimination
Franco, R., Galbraith, J. W., Overton, E. T., & Saag, M. S. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.94 · Cited by 14
Martínez‐Rebollar, M., de la Mora, L., Campistol, M., Cabrera, B., Bagué, A., de Lazzari, E., Torres, B., Gonzalez‐Cordón, A., Inciarte, A., Ambrosioni, J., et al. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00448-0 · Cited by 14
Hepatitis C Virus Treatment as Prevention: Challenges and Opportunities in Men Who Have Sex With Men
Rockstroh, J. K., & Boesecke, C. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa096 · Cited by 13
Self-citationSarrazin, C., Boesecke, C., Golsabahi‐Broclawski, S., Moog, G., Negro, F., Silaidos, C. V., Patel, P., Lohmann, K., Spinner, C. D., Walcher, S., et al. (2021) · Health Science Reports · doi:10.1002/hsr2.290 · Cited by 13
Self-citationBischoff, J., Boesecke, C., Ingiliz, P., Berger, F., Simon, K., Lutz, T., Schewe, K., Wiesch, J. S. Z., Hueppe, D., Christensen, S., et al. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001189 · Cited by 13
Self-citationSchroeder, S., Higgs, P., Winter, R., Brown, G., Pedrana, A. E., Hellard, M. E., Doyle, J., & Stoove, M. A. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25288 · Cited by 13
Incidence and Risk Factors of Reinfection with HCV after Treatment in People Living with HIV
Cheng, C., Ku, S.-Y., Lin, Y., Chen, C., Cheng, S., & Lin, I. (2022) · Viruses · doi:10.3390/v14020439 · Cited by 13
Parczewski, M., Cielniak, I., Kordek, J., Aksak‐Wąs, B., Urbańska, A., Leszczyszyn‐Pynka, M., Siwak, E., Bociąga‐Jasik, M., Nowak, A., Szymczak, A., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001628 · Cited by 12
Prevention of Sexually Transmitted Diseases in HIV-Infected Individuals
Quilter, L. A. S., Dhanireddy, S., & Marrazzo, J. M. (2017) · Current HIV/AIDS Reports · doi:10.1007/s11904-017-0350-3 · Cited by 12
study, O. B. O. T. M., Lambers, F. A. E., van der Veldt, W. M., Prins, M., & Davidovich, U. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3571-1 · Cited by 13
Chen, G., Sun, H., Chang, S., Su, L., Chen, Y., Hsieh, S., Liu, W.-D., Sheng, W., Huang, Y., Lin, K., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2065933 · Cited by 11
Viral hepatitis in persons living with HIV in the post-COVID era
de Mendoza, C., Corral, O. J., Barreiro, P., Soriano, V., & Moreno‐Torres, V. (2023) · Aids Reviews · doi:10.24875/aidsrev.m23000061 · Cited by 11
Koutsoudakis, G., de León, A. P., Herrera, C., Dorner, M., Pérez‐Vilaró, G., Lyonnais, S., Grijalvo, S., Eritja, R., Meyerhans, A., Mirambeau, G., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02354-16 · Cited by 11
Telaprevir-Containing Triple Therapy in Acute HCV Coinfection: The CHAT Study
the CHAT study group, Boesecke, C., Singh, G. K. J., Scholten, S., Lutz, T., Baumgarten, A., Schneeweiß, S. M., Trein, A., Rausch, M., Ingiliz, P., et al. (2016) · Antiviral Therapy · doi:10.3851/imp3143 · Cited by 10
Self-citationSimoncini, G. M., Hou, Q., Carlson, K., Buchacz, K. A., Tedaldi, E., Palella, F. J., Durham, M. D., Li, J., for the HIV Outpatient Study (HOPS) Investigators, Buchacz, K. A., et al. (2021) · AIDS Patient Care and STDs · doi:10.1089/apc.2021.0087 · Cited by 11
Huang, M., Sun, H., Ho, S., Chang, S., Hsieh, S., Sheng, W., Chuang, Y., Huang, Y., Su, L., Liu, W., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i37.6277 · Cited by 10
Liver Disease in Human Immunodeficiency Virus Infection
Oikonomou, K. G., Tsai, E., Sarpel, D., & Dieterich, D. T. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2018.12.011 · Cited by 10
Nijmeijer, B. M., Sarrami‐Forooshani, R., Steba, G. S., Schreurs, R., Koekkoek, S. M., Molenkamp, R., Schinkel, J., Reiss, P., van Heukelom, M. L. S., van der Valk, M., et al. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25268 · Cited by 10
CROI 2019: highlights of viral hepatitis.
Luetkemeyer, A. F., & Wyles, D. L. (2019) · Europe PMC (PubMed Central) · Cited by 10
Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal
Ghosh, A., Romani, S., Kottilil, S., & Poonia, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207473 · Cited by 10
Targeted HCV core antigen monitoring among HIV-positive men who have sex with men is cost-saving
Popping, S., Nichols, B. E., Rijnders, B. J. A., van Kampen, J. J. A., Verbon, A., Boucher, C. A., & van de Vijver, D. A. M. C. (2019) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30031-5 · Cited by 10
Wan, Z., Sun, P., Dzakah, E. E., Huang, L., Shuai, P., & Liu, Y. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.855989 · Cited by 8
Chen, P., Simonetto, D. A., Paul, S., & Patel, A. (2023) · Clinical Liver Disease · doi:10.1097/cld.0000000000000073 · Cited by 8
Prinsenberg, T., Zantkuijl, P., Zuilhof, W., Davidovich, U., Schinkel, J., Prins, M., & van der Valk, M. (2020) · JMIR Formative Research · doi:10.2196/19100 · Cited by 8
Isfordink, C. J., Boyd, A. C., Sacks‐Davis, R., van Santen, D. K., Smit, C., Martinello, M., Stoove, M. A., Berenguer, J., Wittkop, L., Klein, M. B., et al. (2023) · The Lancet Public Health · doi:10.1016/s2468-2667(23)00056-7 · Cited by 8
Self-citationAre there any challenges left in hepatitis C virus therapy of HIV-infected patients?
Bischoff, J., & Rockstroh, J. K. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.08.019 · Cited by 8
Self-citationNijmeijer, B. M., Eder, J., Langedijk, C. J. M., Kaptein, T. M., Meeussen, S., Zimmermann, P., Ribeiro, C. M. S., & Geijtenbeek, T. B. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00503 · Cited by 8
Benefits of Hepatitis C Cure With Antivirals: Why Test and Treat?
Lledó, G. M., Benítez‐Gutiérrez, L., Arias, A., Requena, S., Cuervas‐Mons, V., & de Mendoza, C. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0041 · Cited by 8
Todesco, E., Day, N., Amiel, C., Elaerts, S., Schneider, V., Roudière, L., Hué, S., Liotier, J.-Y., Bottero, J., L'Yavanc, T., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.02.002 · Cited by 7
Self-citation
Metadata
- Authors
- Ingiliz, P., Martin, T. C., Rodger, A., Stellbrink, H.-J., Mauss, S., Boesecke, C., Mandorfer, M., Bottero, J., Baumgarten, A., Bhagani, S., Lacombe, K., Nelson, M., & Rockstroh, J. K.
- Affiliations
- Chelsea and Westminster Hospital (GB)
- The Royal Free Hospital (GB)
- Infektionsmedizinisches Centrum Hamburg (DE)
- Center for HIV and Hepatogastroenterology (DE)
- University of Bonn (DE)
- Medical University of Vienna (AT)
- Assistance Publique – Hôpitaux de Paris (FR)
- Inserm (FR)
- Corresponding author
- Ingiliz, Patrick
- ORCID
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 66
- Issue
- 2
- Pages
- 282-287
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2520350813
- Cited by
- 173
- References
- 39
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 11 · 2023: 10 · 2022: 19 · 2021: 14 · 2020: 19 · 2019: 35 · 2018: 30 · 2017: 18
- FWCI
- 20.96
- Type
- journal article
- Language
- en
- Open access
- green
- discovery.ucl.ac.uk
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion, cc-by-nc-nd)
- HAL (submittedVersion)
- Funders
- NEAT (LSHP-CT-2006-037570)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Keywords
- HIV/HCV coinfection, men who have sex with men, spontaneous HCV clearance, ALT levels
- MeSH terms
- Adult, Antiviral Agents, Communicable Disease Control, Europe, Female, Hepatitis C, HIV Seropositivity, Humans, Male, Middle Aged, HIV Infections, Incidence, Hepacivirus, Homosexuality, Male, Coinfection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
